U.S. NIH – Funding Longevity Innovation and Commercialization

Credit: Mary Furlong
Photo Credit: Mary Furlong

Ira Pastor ideaXme life sciences ambassador and founder of Bioquark, interviews Dr. Todd Haim, Chief of the Office of Small Business Research at National Institute on Aging.

Ira Pastor comments:

On several recent shows, we’ve been discussing some of the novel, alternative funding pools that have been emerging in and around the biotechnology space, specifically related to some un-met medical needs that we have been focusing on in relation to the show, particularly on the age-tech and longevity biotech fronts.

We have had guests join us from the $125 Million Healthy Ageing Challenge program of UKRI (UK Research and Innovation) and the $30 Million Healthy Longevity Global Grand Challenge of the U.S. National Academy of Medicine. We’ve also talked to folks at the XPrize Foundation specifically related to their upcoming inducement prize contest for therapeutics for the diseases of aging.

Small Business Innovation

Today we are going to head into the federal innovation research and development arena and into some of the novel public/private sector partnership opportunities that exist between small businesses and/or nonprofit research institutions, and the U.S. government.

The Small Business Innovation Research (or SBIR) program, is a United States government program, coordinated by the Small Business Administration (SBA), intended to help certain small businesses conduct research and development, where funding takes the form of contracts or grants, and recipient projects must have the potential for commercialization and must meet specific U.S. government R&D needs.

The Small Business Technology Transfer (STTR) Program is a parallel program to the SBIR program, but differs from SBIR in that it places a greater emphasis on the potential for commercial success, and it requires that universities, federal laboratories, or nonprofit research centers team with businesses to get products into the marketplace.

Approximately $2.5 billion is awarded through these programs each year.

Credit: Mary Furlong
Dr. Todd Haim, Photo Credit: Mary Furlong

Dr. Todd Haim, Chief of the Office of Small Business Research at National Institute on Aging (NIA)

I’m honored to be joined by Dr. Todd Haim who is Chief of the Office of Small Business Research at National Institute on Aging (NIA), which is a division of the U.S. National Institutes of Health (NIH), which leads a broad scientific effort to understand the nature of aging and to extend the healthy, active years of life.

Dr. Haim oversees the development and evolution of this office with the goal of improving both the quantity and quality of the SBIR/STTR applications.

Prior to this role, Dr. Haim was Program Director at the National Cancer Institute’s (NCI) SBIR Development Center, where he evaluated and managed SBIR & STTR grants and contracts focused on the development of novel cancer therapeutics, preventative agents, and drug discovery technologies.

Prior to starting in the SBIR Development Center, he was a Research Associate and Christine Mirzayan Science and Technology Policy Fellow at the National Academy of Sciences.

Previously, he has completed a postdoctoral fellowship at Pfizer in which he actively led Pfizer’s research efforts in a collaboration with Washington University School of Medicine in St. Louis that illustrated a mechanism for altered cardiac contractility due to excess fatty acids.

Dr. Haim graduated from Albert Einstein College of Medicine with a PhD in Biomedical Research, specializing in Physiology and Cellular Biophysics, and obtained a certificate in Technology Commercialization from John Hopkins’ Carey Business School.

He has received several prestigious awards and honors including the 2014 NCI Leadership Development Award, a 2014 and 2017 NIH Director’s Award and the NJ Governor’s Award for Volunteerism in the Field of Health.

On this show we will hear about:

Dr. Haim’s background, how he developed an interest in biomedical sciences, physiology and cellular biophysics, and aging. A general overview of the NIA and it’s functions within the U.S. National Institutes of Health. An overview of the NIA SBIR /STTR system. Technological areas of specific interest to the NIA program and to Dr. Haim himself.

Ira Pastor, ideaXme ambassador
Ira Pastor, ideaXme life sciences ambassador

Credits: Ira Pastor interview video, text, and audio.

Follow Ira Pastor on Twitter: @IraSamuelPastor

If you liked this interview, be sure to check out our interview about the Healthy Longevity Global Grand Challenge!

Follow ideaXme on Twitter: @ideaxm

On Instagram: @ideaxme

On YouTube: ideaxme

Find ideaXme across the internet including on iTunes, SoundCloud, Radio Public, TuneIn Radio, I Heart Radio, Google Podcasts, Spotify and more.

ideaXme is a global podcast, creator series and mentor programme. Our mission: Move the human story forward!™ ideaXme Ltd.

2 thoughts on “U.S. NIH – Funding Longevity Innovation and Commercialization

  1. Pingback: Sir David Richmond: $30 Billion Global Threat Of Fake Medicine - ideaXme

  2. Pingback: A Million Volunteers Improving Healthcare for All Of US - ideaXme

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.